Journal
BLOOD
Volume 126, Issue 4, Pages 546-557Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2015-04-637587
Keywords
-
Categories
Funding
- National Heart, Lung and Blood Institute, National Institutes of Health [P01 HL075462]
- Daiichi Sankyo Foundation of Life Science
- Dr. Mildred Scheel Stiftung (Deutsche Krebshilfe)
- Fondazione Italiana per la Ricerca sul Cancro-FIRC
- Interdisciplinary Center for Clinical Research (IZKF), Wurzburg, Germany
- Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom
Ask authors/readers for more resources
The paucity of regulatory T cells (Tregs) limits clinical translation to control aberrant immune reactions including graft-versus-host disease (GVHD). Recent studies showed that theagonisticantibodytoDR3(alpha DR3) expanded CD4(+)FoxP3(+) Tregs in vivo. We investigated whether treating donor mice with a single dose of alpha DR3 could alleviate acute GVHD in a MHC-mismatched bone marrow transplantation model. alpha DR3 induced selective proliferation of functional Tregs. CD4(+) T cells isolated from alpha DR3-treated mice contained higher numbers of Tregs and were less proliferative to allogeneic stimuli. In vivo GVHD studies confirmed that Tregs from alpha DR3-treated donors expanded robustly and higher frequencies of Tregs within donor CD4(+) T cells were maintained, resulting in improved survival. Conventional T cells derived from alpha DR3-treated donors showed reduced activation and proliferation. Serum levels of proinflammatory cytokines (IFN gamma, IL-1 beta, and TNF alpha) and infiltration of donor T cells into GVHD target tissues (gastrointestinal tract and liver) were decreased. T cells from alpha DR3-treated donors retained graft-vs-tumor (GVT) effects. In conclusion, a single dose of alpha DR3 alleviates acute GVHD while preserving GVT effects by selectively expanding and maintaining donor Tregs. This novel strategy will facilitate the clinical application of Treg-based therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available